Shimose, S., Kawaguchi, T., Tanaka, M., Iwamoto, H., Miyazaki, K., Moriyama, E., . . . Torimura, T. (2020). Lenvatinib prolongs the progression-free survival time of patients with intermediate-stage hepatocellular carcinoma refractory to transarterial chemoembolization: A multicenter cohort study using data mining analysis. Oncol Lett.
Citação norma ChicagoShimose, Shigeo, et al. "Lenvatinib Prolongs the Progression-free Survival Time of Patients With Intermediate-stage Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: A Multicenter Cohort Study Using Data Mining Analysis." Oncol Lett 2020.
MLA citiranjeShimose, Shigeo, et al. "Lenvatinib Prolongs the Progression-free Survival Time of Patients With Intermediate-stage Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: A Multicenter Cohort Study Using Data Mining Analysis." Oncol Lett 2020.